Navigation Links
Robert Tungatt, Regulatory Compliance and Cold Chain Excellence Specialist Joins QuickSTAT
Date:9/13/2013

New York, New York (PRWEB) September 13, 2013

Robert Tungatt has joined QuickSTAT as the Global Director of Regulatory Compliance and Cold Chain Excellence. Robert’s unique expertise will help support QuickSTAT’s accelerated growth and global expansion in the pharmaceutical supply chain logistics arena.

With the ever-changing regulatory landscape in Health Care and Pharmaceutical transportation, he will help to ensure that Quick's worldwide clients are compliant and utilize best practices in logistics and cold chain. He will drive continual improvements to ensure timely and safe delivery of urgent and life-saving shipments, where integrity, speed, and high performance levels are essential.

Mr. Tungatt brings a wealth of experience in the specialist logistics and transportation arena, having spent almost 30 years in the industry, with his primary focus in the Healthcare and Life Science industries. His experience includes management positions in Customer Service, Operations and establishing Quality Assurance and Compliance functions under ISO9001 at Marken Limited, where he helped to ensure global compliance. His expertise also includes US and European Aviation Security Compliance.

He is involved in many industry forums, and has helped to develop standards and best practices to help ensure patient safety through a disciplined and best practice mindset. Mr. Tungatt is an active member of AICES (Association of Courier and Express Services), the European Compliance Association and the PDA. Robert is a member of the IATA Time and Temperature Task Force, which is responsible for the Perishable Cargo Regulations, Chapter 17 Air Transport Logistics for Time and Temperature Sensitive Healthcare Products.

“We are pleased to welcome Robert to our team. His experience in Life Science, regulatory compliance, and protocol support will be an asset to QuickSTAT and our clients throughout the world,” says Dominique Brown, COO, The Quick Group of Companies.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11115449.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
2. Robert Farrell Joins Bionovos Board of Directors
3. Engineer Robert J. Wood to receive NSFs Alan T. Waterman Award
4. Fortis Vice President of Nursing Robert Anders Named Academy of Nursing Education Fellow by National League for Nursing
5. Robert Kirsner, MD, PhD, To Present Results For Phase 2b 6-Month Follow-Up Trial Of Unique Investigational Cell-Based Therapy For Venous Leg Ulcers
6. Robert Haynes To Lead Licensing As VR Laboratories Senior Vice President Product Introduction And Licensing
7. Pittcon Announces 2013 Award Recipients; New Award, Robert Boyle Prize for Analytical Science, Added to Technical Program
8. Robert Storey Joins VIC Technology Venture Development as Executive in Residence
9. Roberto DellOro Named Director of LMUs Bioethics Institute
10. Entertainment Agency and Speaker Bureau Mark Sonder Productions Signs the Health & Wellness Shaman, Robert Cohen, PhD, LPC, DCEP for Meetings and Events Worldwide
11. Dr. J. Robert Beyster and Betty J. Beyster Make $2.5 Million Pledge to the J. Craig Venter Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical ... for a host of launch activities including the identification ... this launch activity is especially high in the oncology ... Best Practices and the Role of Medical Affairs ... companies focused on oncology therapies find better ways to ...
(Date:2/5/2016)... , Feb. 5, 2016 Australian-US drug discovery and ... today the appointment of a new Chairman, Mr John ... , effective immediately. James Garner , has ... Director and former Acting CEO, Mr Iain Ross , ... Director. --> James Garner , has also been ...
(Date:2/4/2016)... -- Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the leader ... Lanphier , Sangamo,s president and chief executive officer, will ... Therapeutic ® development programs and an overview of ... Thursday, February 11, 2016, at the Leerink Partners 5 ... being held in New York . ...
(Date:2/4/2016)... China , Feb. 4, 2016 Beike ... and various medical institutions attended a ceremony in late ... integrative, personalized cell therapy in 2016. ... "Shenzhen Clinical Translation Platform for Personalized Cell Therapy" was ... Regional Cell Production Center, both subsidiaries of Beike Biotechnology ...
Breaking Biology Technology:
(Date:2/3/2016)... 2016 --> ... "Automated Fingerprint Identification System Market by Component (Hardware and ... & Finance, Government, Healthcare, and Transportation) and Geography - ... is expected to be worth USD 8.49 Billion by ... and 2020. The transformation and technology evolution from the ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 /PRNewswire/ ... Potentials of that Rising Market Are you ... new analysis forecasts revenues for checkpoint inhibitors. Visiongain,s ... world market, submarket, product and national level. ... Instead discover what progress, opportunities and revenues those ...
(Date:2/1/2016)... , Feb. 1, 2016  Today, the first ... (AHA) announced plans to develop a first of its ... power of IBM Watson. In the first application of ... IBM (NYSE: IBM ), and Welltok will create ... health assessments with cognitive analytics, delivered on Welltok,s health ...
Breaking Biology News(10 mins):